Key result
The SCN5A-G1661R mutation caused a near-complete loss of sodium current density (-7.9 pA/pF vs -113.7 pA/pF for wildtype), with additive genetic burden from GPD1L-A306del aggravating Brugada syndrome severity.
Why the study?
SCN5A loss-of-function variants associate with high phenotypic variability and diverse cardiac presentations, but the underlying mechanisms remain incompletely understood.
The presence of both SCN5A-G1661R and GPD1L-A306del variants additively alters sodium channel function, explaining the severe arrhythmogenic phenotype in double mutation carriers with Brugada syndrome.
No immediate change to Brugada syndrome care; hypothesis-generating for variant interactions and requires prospective validation.
Loss-of-function variants of SCN5A, encoding the sodium channel alpha subunit Nav1.5 are associated with high phenotypic variability and multiple cardiac presentations, while underlying mechanisms are incompletely understood. Here we investigated a family with individuals affected by Brugada Syndrome (BrS) of different severity and aimed to unravel the underlying genetic and electrophysiological basis.Next-generation sequencing was used to identify the genetic variants carried by family members. The index patient, who was severely affected by arrhythmogenic BrS, carried previously uncharacterized variants of Nav1.5 (SCN5A-G1661R) and glycerol-3-phosphate dehydrogenase-1-like protein (GPD1L-A306del) in a double heterozygous conformation. Family members exclusively carrying SCN5A-G1661R showed asymptomatic Brugada ECG patterns, while another patient solely carrying GPD1L-A306del lacked any clinical phenotype.To assess functional mechanisms, Nav1.5 channels were transiently expressed in HEK-293 cells in the presence and absence of GPD1L. Whole-cell patch-clamp recordings revealed loss of sodium currents after homozygous expression of SCN5A-G1661R, and reduction of current amplitude to ~ 50% in cells transfected with equal amounts of wildtype and mutant Nav1.5. Co-expression of wildtype Nav1.5 and GPD1L showed a trend towards increased sodium current amplitudes and a hyperpolarizing shift in steady-state activation and -inactivation compared to sole SCN5A expression. Application of the GPD1L-A306del variant shifted steady-state activation to more hyperpolarized and inactivation to more depolarized potentials.In conclusion, SCN5A-G1661R produces dysfunctional channels and associates with BrS. SCN5A mediated currents are modulated by co-expression of GDP1L and this interaction is altered by mutations in both proteins. Thus, additive genetic burden may aggravate disease severity, explaining higher arrhythmogenicity in double mutation carriers.
No takes yet. Share an insight, caveat, or question.
Semino et al. (2023) studied Brugada syndrome (n=4). SCN5A-G1661R and GPD1L-A306del variants vs. Wildtype SCN5A and GPD1L was evaluated on Sodium current density at -10 mV in transfected HEK-293 cells (p=<0.0001). The SCN5A-G1661R mutation caused a near-complete loss of sodium current density (-7.9 pA/pF vs -113.7 pA/pF for wildtype), with additive genetic burden from GPD1L-A306del aggravating Brugada syndrome severity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: